| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 3.44e-04 | 749 | 10 | 4 | GO:0005509 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 2.91e-06 | 61 | 10 | 3 | GO:1902895 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 3.17e-06 | 6 | 10 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 3.17e-06 | 6 | 10 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 4.44e-06 | 7 | 10 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 4.44e-06 | 7 | 10 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 5.01e-06 | 73 | 10 | 3 | GO:2000630 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 7.39e-06 | 83 | 10 | 3 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 7.66e-06 | 84 | 10 | 3 | GO:0061614 | |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 1.16e-05 | 11 | 10 | 2 | GO:0072102 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 1.41e-05 | 103 | 10 | 3 | GO:2000628 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 2.18e-05 | 119 | 10 | 3 | GO:0010586 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 7.94e-05 | 28 | 10 | 2 | GO:0051152 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 9.14e-05 | 30 | 10 | 2 | GO:0072012 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 9.76e-05 | 31 | 10 | 2 | GO:0061440 | |
| GeneOntologyBiologicalProcess | renal system vasculature development | 9.76e-05 | 31 | 10 | 2 | GO:0061437 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 1.18e-04 | 210 | 10 | 3 | GO:0007219 | |
| GeneOntologyBiologicalProcess | positive regulation of BMP signaling pathway | 1.80e-04 | 42 | 10 | 2 | GO:0030513 | |
| GeneOntologyBiologicalProcess | cell fate determination | 2.56e-04 | 50 | 10 | 2 | GO:0001709 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell differentiation | 2.99e-04 | 54 | 10 | 2 | GO:0051150 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 4.81e-04 | 338 | 10 | 3 | GO:0045165 | |
| GeneOntologyBiologicalProcess | glomerulus development | 6.07e-04 | 77 | 10 | 2 | GO:0032835 | |
| GeneOntologyBiologicalProcess | positive regulation of fibroblast proliferation | 7.39e-04 | 85 | 10 | 2 | GO:0048146 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 8.65e-04 | 92 | 10 | 2 | GO:0048844 | |
| GeneOntologyBiologicalProcess | smooth muscle cell differentiation | 1.00e-03 | 99 | 10 | 2 | GO:0051145 | |
| GeneOntologyBiologicalProcess | neuroinflammatory response | 1.04e-03 | 101 | 10 | 2 | GO:0150076 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 1.10e-03 | 104 | 10 | 2 | GO:0007405 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 1.15e-03 | 106 | 10 | 2 | GO:0051149 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.35e-03 | 115 | 10 | 2 | GO:0090100 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 1.42e-03 | 1125 | 10 | 4 | GO:0035239 | |
| GeneOntologyBiologicalProcess | bone remodeling | 1.64e-03 | 127 | 10 | 2 | GO:0046849 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 1.74e-03 | 131 | 10 | 2 | GO:0030510 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | 1.75e-03 | 1190 | 10 | 4 | GO:0008284 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 1.77e-03 | 1194 | 10 | 4 | GO:0000902 | |
| GeneOntologyBiologicalProcess | artery development | 1.80e-03 | 133 | 10 | 2 | GO:0060840 | |
| GeneOntologyBiologicalProcess | regulation of fibroblast proliferation | 1.85e-03 | 135 | 10 | 2 | GO:0048145 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell proliferation | 1.93e-03 | 138 | 10 | 2 | GO:0048661 | |
| GeneOntologyBiologicalProcess | gland development | 2.05e-03 | 558 | 10 | 3 | GO:0048732 | |
| GeneOntologyBiologicalProcess | fibroblast proliferation | 2.58e-03 | 160 | 10 | 2 | GO:0048144 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 2.76e-03 | 619 | 10 | 3 | GO:0002009 | |
| GeneOntologyBiologicalProcess | nephron development | 3.05e-03 | 174 | 10 | 2 | GO:0072006 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 3.10e-03 | 1390 | 10 | 4 | GO:0045944 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 3.18e-03 | 178 | 10 | 2 | GO:0022612 | |
| GeneOntologyBiologicalProcess | tube development | 3.20e-03 | 1402 | 10 | 4 | GO:0035295 | |
| GeneOntologyBiologicalProcess | circulatory system development | 3.55e-03 | 1442 | 10 | 4 | GO:0072359 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 3.88e-03 | 197 | 10 | 2 | GO:0030509 | |
| GeneOntologyBiologicalProcess | placenta development | 3.88e-03 | 197 | 10 | 2 | GO:0001890 | |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 3.96e-03 | 199 | 10 | 2 | GO:0051147 | |
| GeneOntologyBiologicalProcess | angiogenesis | 4.03e-03 | 708 | 10 | 3 | GO:0001525 | |
| GeneOntologyBiologicalProcess | liver development | 4.08e-03 | 202 | 10 | 2 | GO:0001889 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 4.20e-03 | 205 | 10 | 2 | GO:0061008 | |
| GeneOntologyBiologicalProcess | response to BMP | 4.61e-03 | 215 | 10 | 2 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 4.61e-03 | 215 | 10 | 2 | GO:0071773 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 4.74e-03 | 750 | 10 | 3 | GO:0048729 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell proliferation | 5.16e-03 | 228 | 10 | 2 | GO:0048660 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 5.39e-03 | 233 | 10 | 2 | GO:0061351 | |
| GeneOntologyBiologicalProcess | smooth muscle cell proliferation | 5.57e-03 | 237 | 10 | 2 | GO:0048659 | |
| GeneOntologyBiologicalProcess | positive regulation of ERK1 and ERK2 cascade | 5.71e-03 | 240 | 10 | 2 | GO:0070374 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 5.73e-03 | 802 | 10 | 3 | GO:0048812 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 6.03e-03 | 817 | 10 | 3 | GO:0048514 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 6.07e-03 | 819 | 10 | 3 | GO:0120039 | |
| GeneOntologyBiologicalProcess | circadian rhythm | 6.08e-03 | 248 | 10 | 2 | GO:0007623 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 6.22e-03 | 826 | 10 | 3 | GO:0048858 | |
| GeneOntologyCellularComponent | cell surface | 8.46e-05 | 1111 | 10 | 5 | GO:0009986 | |
| GeneOntologyCellularComponent | Golgi membrane | 2.50e-04 | 721 | 10 | 4 | GO:0000139 | |
| GeneOntologyCellularComponent | receptor complex | 2.22e-03 | 581 | 10 | 3 | GO:0043235 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | 2.26e-03 | 1293 | 10 | 4 | GO:0005789 | |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | 2.30e-03 | 1299 | 10 | 4 | GO:0098827 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | 2.49e-03 | 1327 | 10 | 4 | GO:0042175 | |
| GeneOntologyCellularComponent | leading edge membrane | 4.29e-03 | 210 | 10 | 2 | GO:0031256 | |
| GeneOntologyCellularComponent | early endosome membrane | 4.37e-03 | 212 | 10 | 2 | GO:0031901 | |
| HumanPheno | Platybasia | 1.04e-04 | 17 | 5 | 2 | HP:0002691 | |
| HumanPheno | Dural ectasia | 2.11e-04 | 24 | 5 | 2 | HP:0100775 | |
| HumanPheno | Biconcave vertebral bodies | 2.29e-04 | 25 | 5 | 2 | HP:0004586 | |
| HumanPheno | Abnormal spinal meningeal morphology | 2.29e-04 | 25 | 5 | 2 | HP:0010303 | |
| HumanPheno | Syringomyelia | 4.02e-04 | 33 | 5 | 2 | HP:0003396 | |
| HumanPheno | Increased blood pressure | 4.51e-04 | 508 | 5 | 4 | HP:0032263 | |
| HumanPheno | Hypertension | 4.51e-04 | 508 | 5 | 4 | HP:0000822 | |
| HumanPheno | Ischemic stroke | 5.34e-04 | 38 | 5 | 2 | HP:0002140 | |
| HumanPheno | Cerebral infarct | 5.63e-04 | 39 | 5 | 2 | HP:0025722 | |
| HumanPheno | Abnormal systemic blood pressure | 7.03e-04 | 569 | 5 | 4 | HP:0030972 | |
| HumanPheno | Spinal cord lesion | 7.84e-04 | 46 | 5 | 2 | HP:0100561 | |
| MousePheno | decreased trabecular bone connectivity density | 5.50e-05 | 16 | 10 | 2 | MP:0010933 | |
| MousePheno | abnormal osteoblast morphology | 1.05e-04 | 137 | 10 | 3 | MP:0004986 | |
| MousePheno | abnormal trabecular bone connectivity density | 1.60e-04 | 27 | 10 | 2 | MP:0010931 | |
| Domain | Notch_NODP_dom | 4.42e-10 | 4 | 10 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 4.42e-10 | 4 | 10 | 3 | IPR010660 | |
| Domain | NOD | 4.42e-10 | 4 | 10 | 3 | PF06816 | |
| Domain | Notch | 4.42e-10 | 4 | 10 | 3 | IPR008297 | |
| Domain | NOD | 4.42e-10 | 4 | 10 | 3 | SM01338 | |
| Domain | NODP | 4.42e-10 | 4 | 10 | 3 | SM01339 | |
| Domain | NODP | 4.42e-10 | 4 | 10 | 3 | PF07684 | |
| Domain | LNR | 1.10e-09 | 5 | 10 | 3 | PS50258 | |
| Domain | Notch_dom | 3.86e-09 | 7 | 10 | 3 | IPR000800 | |
| Domain | Notch | 3.86e-09 | 7 | 10 | 3 | PF00066 | |
| Domain | NL | 3.86e-09 | 7 | 10 | 3 | SM00004 | |
| Domain | Growth_fac_rcpt_ | 9.29e-09 | 156 | 10 | 5 | IPR009030 | |
| Domain | EGF_CA | 8.61e-08 | 86 | 10 | 4 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.40e-07 | 97 | 10 | 4 | IPR018097 | |
| Domain | EGF_CA | 1.52e-07 | 99 | 10 | 4 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.00e-07 | 106 | 10 | 4 | IPR000152 | |
| Domain | EGF_CA | 3.53e-07 | 122 | 10 | 4 | SM00179 | |
| Domain | hEGF | 3.60e-07 | 28 | 10 | 3 | PF12661 | |
| Domain | EGF-like_Ca-bd_dom | 3.77e-07 | 124 | 10 | 4 | IPR001881 | |
| Domain | EGF | 4.02e-07 | 126 | 10 | 4 | PF00008 | |
| Domain | DUF3454_notch | 7.74e-07 | 3 | 10 | 2 | IPR024600 | |
| Domain | DUF3454 | 7.74e-07 | 3 | 10 | 2 | SM01334 | |
| Domain | DUF3454 | 7.74e-07 | 3 | 10 | 2 | PF11936 | |
| Domain | EGF | 4.83e-06 | 235 | 10 | 4 | SM00181 | |
| Domain | EGF_3 | 4.83e-06 | 235 | 10 | 4 | PS50026 | |
| Domain | EGF-like_dom | 6.08e-06 | 249 | 10 | 4 | IPR000742 | |
| Domain | EGF_1 | 6.68e-06 | 255 | 10 | 4 | PS00022 | |
| Domain | EGF-like_CS | 7.33e-06 | 261 | 10 | 4 | IPR013032 | |
| Domain | EGF_2 | 7.78e-06 | 265 | 10 | 4 | PS01186 | |
| Domain | ASX_HYDROXYL | 1.74e-05 | 100 | 10 | 3 | PS00010 | |
| Domain | Ank_2 | 1.70e-04 | 215 | 10 | 3 | PF12796 | |
| Domain | Ank | 2.02e-04 | 228 | 10 | 3 | PF00023 | |
| Domain | - | 2.59e-04 | 248 | 10 | 3 | 1.25.40.20 | |
| Domain | ANK | 2.68e-04 | 251 | 10 | 3 | SM00248 | |
| Domain | ANK_REPEAT | 2.75e-04 | 253 | 10 | 3 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 2.78e-04 | 254 | 10 | 3 | IPR020683 | |
| Domain | ANK_REP_REGION | 2.78e-04 | 254 | 10 | 3 | PS50297 | |
| Domain | Ankyrin_rpt | 3.04e-04 | 262 | 10 | 3 | IPR002110 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 4.50e-10 | 24 | 8 | 4 | M11190 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.20e-09 | 5 | 8 | 3 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 2.40e-09 | 6 | 8 | 3 | M27068 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 1.98e-08 | 11 | 8 | 3 | M47865 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 2.63e-08 | 12 | 8 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 2.63e-08 | 12 | 8 | 3 | M47533 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.42e-08 | 68 | 8 | 4 | M27303 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 3.42e-08 | 13 | 8 | 3 | M47423 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 3.42e-08 | 13 | 8 | 3 | M47534 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 7.31e-08 | 82 | 8 | 4 | MM15922 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 9.75e-08 | 18 | 8 | 3 | M614 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.49e-07 | 27 | 8 | 3 | M39545 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.90e-07 | 28 | 8 | 3 | M6177 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 6.89e-07 | 143 | 8 | 4 | M27275 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 7.12e-07 | 34 | 8 | 3 | M39390 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 9.27e-07 | 154 | 8 | 4 | M39739 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.09e-06 | 39 | 8 | 3 | MM14604 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.68e-06 | 45 | 8 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.80e-06 | 46 | 8 | 3 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.92e-06 | 47 | 8 | 3 | M7946 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.82e-06 | 5 | 8 | 2 | MM14733 | |
| Pathway | PID_NOTCH_PATHWAY | 3.84e-06 | 59 | 8 | 3 | M17 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 4.25e-06 | 61 | 8 | 3 | M39540 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 5.91e-06 | 7 | 8 | 2 | MM14734 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 6.00e-06 | 246 | 8 | 4 | M10189 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 6.39e-06 | 250 | 8 | 4 | M27554 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.72e-05 | 97 | 8 | 3 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 1.95e-05 | 101 | 8 | 3 | M39448 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.11e-05 | 118 | 8 | 3 | M39852 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 3.18e-05 | 119 | 8 | 3 | M607 | |
| Pathway | PID_SYNDECAN_3_PATHWAY | 3.82e-05 | 17 | 8 | 2 | M251 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.80e-05 | 19 | 8 | 2 | MM15594 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 5.33e-05 | 20 | 8 | 2 | M27881 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 7.09e-05 | 23 | 8 | 2 | MM14954 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 7.85e-05 | 161 | 8 | 3 | M39770 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 8.40e-05 | 25 | 8 | 2 | M27879 | |
| Pathway | WP_CANCER_PATHWAYS | 1.03e-04 | 507 | 8 | 4 | M48302 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.86e-04 | 37 | 8 | 2 | M39506 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 3.27e-04 | 49 | 8 | 2 | M618 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 3.97e-04 | 1387 | 8 | 5 | M734 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 7.46e-04 | 74 | 8 | 2 | M39857 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 9.15e-04 | 82 | 8 | 2 | M594 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 1.03e-03 | 87 | 8 | 2 | M39465 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 5.83e-03 | 210 | 8 | 2 | MM15043 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 6.21e-03 | 217 | 8 | 2 | M18437 | |
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 9.41e-11 | 4 | 11 | 3 | 28061457 | |
| Pubmed | 9.41e-11 | 4 | 11 | 3 | 24145721 | ||
| Pubmed | 9.41e-11 | 4 | 11 | 3 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 9.41e-11 | 4 | 11 | 3 | 19404845 | |
| Pubmed | 9.41e-11 | 4 | 11 | 3 | 28669409 | ||
| Pubmed | 9.41e-11 | 4 | 11 | 3 | 11466531 | ||
| Pubmed | 9.41e-11 | 4 | 11 | 3 | 24151014 | ||
| Pubmed | 9.41e-11 | 4 | 11 | 3 | 11401408 | ||
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 9.41e-11 | 4 | 11 | 3 | 10194420 | |
| Pubmed | Functional conservation of mouse Notch receptor family members. | 9.41e-11 | 4 | 11 | 3 | 8898100 | |
| Pubmed | 9.41e-11 | 4 | 11 | 3 | 11459941 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 9.41e-11 | 4 | 11 | 3 | 18184405 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 9.41e-11 | 4 | 11 | 3 | 15917835 | |
| Pubmed | 9.41e-11 | 4 | 11 | 3 | 23444212 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 9.41e-11 | 4 | 11 | 3 | 17920003 | |
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 2.35e-10 | 5 | 11 | 3 | 21726900 | |
| Pubmed | 2.35e-10 | 5 | 11 | 3 | 21124806 | ||
| Pubmed | 2.35e-10 | 5 | 11 | 3 | 23675950 | ||
| Pubmed | 2.35e-10 | 5 | 11 | 3 | 11101851 | ||
| Pubmed | 2.35e-10 | 5 | 11 | 3 | 15882997 | ||
| Pubmed | 4.70e-10 | 6 | 11 | 3 | 9111338 | ||
| Pubmed | 4.70e-10 | 6 | 11 | 3 | 20870902 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 4.70e-10 | 6 | 11 | 3 | 12244553 | |
| Pubmed | 4.70e-10 | 6 | 11 | 3 | 19503073 | ||
| Pubmed | 4.70e-10 | 6 | 11 | 3 | 18299578 | ||
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 4.70e-10 | 6 | 11 | 3 | 15019995 | |
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 4.70e-10 | 6 | 11 | 3 | 22615412 | |
| Pubmed | Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice. | 4.70e-10 | 6 | 11 | 3 | 21991352 | |
| Pubmed | 8.23e-10 | 7 | 11 | 3 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 8.23e-10 | 7 | 11 | 3 | 12846471 | |
| Pubmed | Murine notch homologs (N1-4) undergo presenilin-dependent proteolysis. | 8.23e-10 | 7 | 11 | 3 | 11518718 | |
| Pubmed | 1.32e-09 | 8 | 11 | 3 | 22156581 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 1.32e-09 | 8 | 11 | 3 | 12242716 | |
| Pubmed | 1.32e-09 | 8 | 11 | 3 | 9858718 | ||
| Pubmed | 1.97e-09 | 9 | 11 | 3 | 11118901 | ||
| Pubmed | 1.97e-09 | 9 | 11 | 3 | 16245338 | ||
| Pubmed | 1.97e-09 | 9 | 11 | 3 | 12370315 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 2.82e-09 | 10 | 11 | 3 | 23665443 | |
| Pubmed | 2.82e-09 | 10 | 11 | 3 | 33915108 | ||
| Pubmed | Jag2-Notch1 signaling regulates oral epithelial differentiation and palate development. | 3.88e-09 | 11 | 11 | 3 | 16607638 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 3.88e-09 | 11 | 11 | 3 | 15499562 | |
| Pubmed | 3.88e-09 | 11 | 11 | 3 | 10878608 | ||
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 3.88e-09 | 11 | 11 | 3 | 9187150 | |
| Pubmed | 3.88e-09 | 11 | 11 | 3 | 12866128 | ||
| Pubmed | 5.17e-09 | 12 | 11 | 3 | 10952889 | ||
| Pubmed | 5.17e-09 | 12 | 11 | 3 | 15465494 | ||
| Pubmed | A regulatory T cell Notch4-GDF15 axis licenses tissue inflammation in asthma. | 6.72e-09 | 13 | 11 | 3 | 32929274 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 6.72e-09 | 13 | 11 | 3 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 6.72e-09 | 13 | 11 | 3 | 20558824 | |
| Pubmed | Cell-fate transition and determination analysis of mouse male germ cells throughout development. | 8.55e-09 | 14 | 11 | 3 | 34824237 | |
| Pubmed | 8.55e-09 | 14 | 11 | 3 | 14757642 | ||
| Pubmed | Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. | 1.07e-08 | 15 | 11 | 3 | 14672936 | |
| Pubmed | 1.07e-08 | 15 | 11 | 3 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 1.32e-08 | 16 | 11 | 3 | 12617809 | |
| Pubmed | 1.32e-08 | 16 | 11 | 3 | 10842072 | ||
| Pubmed | 1.32e-08 | 16 | 11 | 3 | 17273555 | ||
| Pubmed | Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. | 1.32e-08 | 16 | 11 | 3 | 11739954 | |
| Pubmed | The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells. | 1.32e-08 | 16 | 11 | 3 | 27641601 | |
| Pubmed | 1.32e-08 | 16 | 11 | 3 | 32161758 | ||
| Pubmed | 1.60e-08 | 17 | 11 | 3 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.60e-08 | 17 | 11 | 3 | 15821257 | |
| Pubmed | 1.60e-08 | 17 | 11 | 3 | 39315665 | ||
| Pubmed | 1.92e-08 | 18 | 11 | 3 | 18093989 | ||
| Pubmed | 1.92e-08 | 18 | 11 | 3 | 15689374 | ||
| Pubmed | 2.27e-08 | 19 | 11 | 3 | 16518823 | ||
| Pubmed | 3.12e-08 | 21 | 11 | 3 | 28656980 | ||
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 3.12e-08 | 21 | 11 | 3 | 14702043 | |
| Pubmed | 3.61e-08 | 22 | 11 | 3 | 34998785 | ||
| Pubmed | 4.15e-08 | 23 | 11 | 3 | 14701881 | ||
| Pubmed | 4.15e-08 | 23 | 11 | 3 | 36239412 | ||
| Pubmed | Rbpj regulates development of prosensory cells in the mammalian inner ear. | 4.75e-08 | 24 | 11 | 3 | 21420948 | |
| Pubmed | 5.39e-08 | 25 | 11 | 3 | 21786021 | ||
| Pubmed | 6.09e-08 | 26 | 11 | 3 | 25446530 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 6.09e-08 | 26 | 11 | 3 | 19369401 | |
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 6.86e-08 | 27 | 11 | 3 | 21791528 | |
| Pubmed | 7.68e-08 | 28 | 11 | 3 | 19914171 | ||
| Pubmed | 8.56e-08 | 29 | 11 | 3 | 25535917 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 8.56e-08 | 29 | 11 | 3 | 21402740 | |
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 11532344 | ||
| Pubmed | Transcriptomic data showing differentially expressed genes between Notch3 and Notch4 deleted mice. | 9.09e-08 | 2 | 11 | 2 | 33665264 | |
| Pubmed | Expression of notch family proteins in placentas from patients with early-onset severe preeclampsia. | 9.09e-08 | 2 | 11 | 2 | 24336671 | |
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 34257585 | ||
| Pubmed | Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. | 9.09e-08 | 2 | 11 | 2 | 17696940 | |
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 25658374 | ||
| Pubmed | Effects of Notch2 and Notch3 on Cell Proliferation and Apoptosis of Trophoblast Cell Lines. | 9.09e-08 | 2 | 11 | 2 | 26640406 | |
| Pubmed | Notch2 and Notch3 function together to regulate vascular smooth muscle development. | 9.09e-08 | 2 | 11 | 2 | 22615991 | |
| Pubmed | A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. | 9.09e-08 | 2 | 11 | 2 | 11777956 | |
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 23587900 | ||
| Pubmed | 9.09e-08 | 2 | 11 | 2 | 20643108 | ||
| Pubmed | Notch signaling regulates ovarian follicle formation and coordinates follicular growth. | 9.51e-08 | 30 | 11 | 3 | 24552588 | |
| Pubmed | 9.51e-08 | 30 | 11 | 3 | 16524929 | ||
| Pubmed | 1.05e-07 | 31 | 11 | 3 | 37573008 | ||
| Pubmed | 1.40e-07 | 34 | 11 | 3 | 17015435 | ||
| Pubmed | 1.40e-07 | 34 | 11 | 3 | 21311046 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 1.53e-07 | 35 | 11 | 3 | 21252157 | |
| Pubmed | 1.82e-07 | 37 | 11 | 3 | 24673559 | ||
| Pubmed | 2.49e-07 | 41 | 11 | 3 | 22675208 | ||
| Pubmed | Notch3 cooperates with the EGFR pathway to modulate apoptosis through the induction of bim. | 2.73e-07 | 3 | 11 | 2 | 19881544 | |
| Pubmed | 2.73e-07 | 3 | 11 | 2 | 7615640 | ||
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 2.73e-07 | 3 | 11 | 2 | 25846406 | |
| Interaction | MAML2 interactions | 8.19e-08 | 17 | 11 | 3 | int:MAML2 | |
| Interaction | MAML3 interactions | 1.37e-07 | 20 | 11 | 3 | int:MAML3 | |
| Interaction | NOTCH4 interactions | 1.60e-07 | 21 | 11 | 3 | int:NOTCH4 | |
| Interaction | FBXO2 interactions | 1.44e-06 | 411 | 11 | 5 | int:FBXO2 | |
| Interaction | NOTCH2 interactions | 1.66e-06 | 423 | 11 | 5 | int:NOTCH2 | |
| Interaction | CD248 interactions | 5.68e-06 | 7 | 11 | 2 | int:CD248 | |
| Interaction | MAML1 interactions | 7.37e-06 | 73 | 11 | 3 | int:MAML1 | |
| Interaction | EGFL7 interactions | 8.66e-06 | 77 | 11 | 3 | int:EGFL7 | |
| Interaction | PSEN2 interactions | 1.21e-05 | 86 | 11 | 3 | int:PSEN2 | |
| Interaction | DEFA1 interactions | 1.90e-05 | 100 | 11 | 3 | int:DEFA1 | |
| Interaction | RABGGTB interactions | 2.39e-05 | 108 | 11 | 3 | int:RABGGTB | |
| Interaction | IGSF5 interactions | 2.46e-05 | 14 | 11 | 2 | int:IGSF5 | |
| Interaction | AGRP interactions | 2.46e-05 | 14 | 11 | 2 | int:AGRP | |
| Interaction | NOTCH3 interactions | 2.74e-05 | 113 | 11 | 3 | int:NOTCH3 | |
| Interaction | FBLN1 interactions | 4.07e-05 | 129 | 11 | 3 | int:FBLN1 | |
| Interaction | CASR interactions | 6.22e-05 | 22 | 11 | 2 | int:CASR | |
| Interaction | NTN5 interactions | 7.43e-05 | 24 | 11 | 2 | int:NTN5 | |
| Interaction | LRATD2 interactions | 1.42e-04 | 33 | 11 | 2 | int:LRATD2 | |
| Interaction | DLL1 interactions | 1.88e-04 | 38 | 11 | 2 | int:DLL1 | |
| Interaction | PSEN1 interactions | 2.18e-04 | 227 | 11 | 3 | int:PSEN1 | |
| Interaction | JAG1 interactions | 2.20e-04 | 41 | 11 | 2 | int:JAG1 | |
| Interaction | LRRIQ1 interactions | 2.42e-04 | 43 | 11 | 2 | int:LRRIQ1 | |
| Interaction | TFAP2C interactions | 2.53e-04 | 44 | 11 | 2 | int:TFAP2C | |
| Interaction | GGH interactions | 2.66e-04 | 243 | 11 | 3 | int:GGH | |
| Interaction | ANKRD44 interactions | 3.01e-04 | 48 | 11 | 2 | int:ANKRD44 | |
| Interaction | RBPJ interactions | 3.03e-04 | 254 | 11 | 3 | int:RBPJ | |
| Interaction | FOXD4L6 interactions | 3.14e-04 | 49 | 11 | 2 | int:FOXD4L6 | |
| Interaction | DIRAS3 interactions | 3.32e-04 | 262 | 11 | 3 | int:DIRAS3 | |
| Interaction | GRN interactions | 4.07e-04 | 281 | 11 | 3 | int:GRN | |
| Interaction | RET interactions | 4.20e-04 | 284 | 11 | 3 | int:RET | |
| Interaction | PRG2 interactions | 4.25e-04 | 285 | 11 | 3 | int:PRG2 | |
| Interaction | ZFP41 interactions | 4.25e-04 | 57 | 11 | 2 | int:ZFP41 | |
| Interaction | WDR25 interactions | 4.40e-04 | 58 | 11 | 2 | int:WDR25 | |
| GeneFamily | Ankyrin repeat domain containing | 1.26e-04 | 242 | 8 | 3 | 403 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.07e-08 | 16 | 11 | 3 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.07e-08 | 16 | 11 | 3 | MM1296 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 1.39e-05 | 385 | 11 | 4 | M39264 | |
| Coexpression | JEON_SMAD6_TARGETS_DN | 2.73e-05 | 19 | 11 | 2 | M13678 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 5.59e-05 | 27 | 11 | 2 | MM1135 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 5.59e-05 | 27 | 11 | 2 | M1391 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 7.89e-05 | 32 | 11 | 2 | M5903 | |
| Coexpression | LIU_CDX2_TARGETS_UP | 9.46e-05 | 35 | 11 | 2 | M16637 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 2.04e-04 | 767 | 11 | 4 | M39209 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 2.34e-04 | 795 | 11 | 4 | M39050 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 4.07e-04 | 365 | 11 | 3 | M39018 | |
| Coexpression | JONES_OVARY_NK_CELL | 6.15e-04 | 89 | 11 | 2 | M48353 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 5.18e-05 | 905 | 11 | 5 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#4_top-relative-expression-ranked_1000 | 9.25e-05 | 179 | 11 | 3 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k4_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.09e-04 | 236 | 11 | 3 | gudmap_kidney_P3_CapMes_Crym_k1_1000 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.95e-04 | 293 | 11 | 3 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000 | 4.16e-04 | 749 | 11 | 4 | gudmap_kidney_P3_CapMes_Crym_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 4.92e-04 | 783 | 11 | 4 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 6.98e-04 | 356 | 11 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 7.44e-04 | 364 | 11 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.62e-08 | 157 | 11 | 4 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-07 | 191 | 11 | 4 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.22e-07 | 200 | 11 | 4 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-06 | 156 | 11 | 3 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.87e-06 | 158 | 11 | 3 | 551e3fd7cabc94ba933607ccdcf93f4e799be43a | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-3|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 7.27e-06 | 161 | 11 | 3 | 52239a887799362256ecd7e740b716b88ed59a62 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Striatum / BrainAtlas - Mouse McCarroll V32 | 7.68e-06 | 164 | 11 | 3 | e24b06a14565f7798ac50c2fe3f34d4547b9000e | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 170 | 11 | 3 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.55e-06 | 170 | 11 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.70e-06 | 171 | 11 | 3 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-06 | 173 | 11 | 3 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.01e-06 | 173 | 11 | 3 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteochondral_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.98e-06 | 179 | 11 | 3 | 98c0c5c8034ae8a4b3ceea7fd1d0386ee5f89d09 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 180 | 11 | 3 | b6f44fdedc33b7d93b0074e8e9c8cc32009d4c4d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-05 | 183 | 11 | 3 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-05 | 184 | 11 | 3 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-05 | 184 | 11 | 3 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 184 | 11 | 3 | 94748f63947db79a6b4540e3090a63689fdd9452 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 184 | 11 | 3 | 819b277ecced7b415e363c7e7ddbc6f3b2d296de | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.08e-05 | 184 | 11 | 3 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 185 | 11 | 3 | 38486b69c48dc5e1c4e1488208fa8954a973eccb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 185 | 11 | 3 | 3c28b5ceba3cfdb6f7e32d5b42e03b6a81a7a658 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-05 | 187 | 11 | 3 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.14e-05 | 187 | 11 | 3 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 188 | 11 | 3 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.16e-05 | 188 | 11 | 3 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 1.17e-05 | 189 | 11 | 3 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 189 | 11 | 3 | a959c9d6a0866582688a4204d625c1e5a123e93d | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.17e-05 | 189 | 11 | 3 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-05 | 189 | 11 | 3 | ca3a04c202afc32aa11d17154066ef7dc6d01405 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.17e-05 | 189 | 11 | 3 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 190 | 11 | 3 | 048b581e3f7ea9fc2f87c0532974bba85c7292c2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 190 | 11 | 3 | 1121eb607a984c59fbffe7220837fc178745aa55 | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 1.19e-05 | 190 | 11 | 3 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.19e-05 | 190 | 11 | 3 | 84fbd5664ec886120963d4f50dfa1fd1851d36c1 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 191 | 11 | 3 | 96ff4cfbdcaec4b8568f9482d732dddd399121d3 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-05 | 191 | 11 | 3 | 8597a8af294f24496c317d995f07eb5dcc25c13c | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 192 | 11 | 3 | 6d4fe7ea278efa4b9d43f8a3c282bc0e0e9abaea | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 192 | 11 | 3 | 47aed7c8e6f5ce1084821212a04f568319e65fd6 | |
| ToppCell | facs-Aorta-Heart-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 192 | 11 | 3 | 2c6406bc97c3224099b94a43f2890f057b528fa6 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.23e-05 | 192 | 11 | 3 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | P03-Mesenchymal-developing_mesenchymal_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.23e-05 | 192 | 11 | 3 | 063e119c4b58957643908f667e6cfd6f7517fd03 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 192 | 11 | 3 | 3617d2bc7e33d981f3ec349e9962d8d4bd822fbd | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-05 | 193 | 11 | 3 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-05 | 193 | 11 | 3 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.25e-05 | 193 | 11 | 3 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 11 | 3 | 3bff2e4eb16719ab7419b2f94c9c6e7302aa6629 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 11 | 3 | 80be44e9ddd9f6ddd9dff7cba0eb457431204c2d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 11 | 3 | b35e33439b6d3b5d69147e617224d2c8fd056223 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 11 | 3 | bf34737ae2dc218f890fbb9201c308b324415749 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 11 | 3 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 11 | 3 | 4ebed7a6731b88c8359860072cbeba355a7e90ac | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 194 | 11 | 3 | fdaf61cbe7f77ff5358d150b38adb1fe3778e961 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 196 | 11 | 3 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 196 | 11 | 3 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 196 | 11 | 3 | e224338490691d92c1f70b57112fabdcc92b06a9 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-05 | 197 | 11 | 3 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 197 | 11 | 3 | c10dd1aaec01fb662eac83dfde90e3e426665d65 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-05 | 197 | 11 | 3 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.33e-05 | 197 | 11 | 3 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-05 | 197 | 11 | 3 | 8c728cd3c0382c4f3e4b78647b6e1447bb40ace1 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-05 | 197 | 11 | 3 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-05 | 197 | 11 | 3 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-05 | 197 | 11 | 3 | 2844dbcd0a673ed81c99920aa45858651a00736d | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.33e-05 | 197 | 11 | 3 | c165c6fd12dc649b39e920d8528e2eb65c61956b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-05 | 198 | 11 | 3 | b258f672529fb2c03e62e2696d335043c4963280 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.35e-05 | 198 | 11 | 3 | 55e583321f60c95898d93cd0d2615c6692db52ec | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 198 | 11 | 3 | 76d46950c11cb4708866db0da54ce00d5c0adab8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-05 | 198 | 11 | 3 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 11 | 3 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 11 | 3 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-05 | 199 | 11 | 3 | 251b3643dcd8f4645b17101bd716e66f12a20e88 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-05 | 199 | 11 | 3 | e19b296d583f8bad3b66ee998a8153634d6fe09e | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-05 | 199 | 11 | 3 | 117f4f43b6c06dda553799b1063e827bce697370 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.37e-05 | 199 | 11 | 3 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial|World / Primary Cells by Cluster | 1.37e-05 | 199 | 11 | 3 | b9763ac9857a60db6f1f104fe1e9ea2266cf931b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-05 | 199 | 11 | 3 | 9b2262edbdec89166d895ab97527e0ee5f9b6010 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-05 | 199 | 11 | 3 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.37e-05 | 199 | 11 | 3 | 801887db51ac5dc5b068808ff75e3a46643398e9 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial|World / Primary Cells by Cluster | 1.37e-05 | 199 | 11 | 3 | 9e01eee126247a0696c71b019f855a8a41a0ede3 | |
| ToppCell | Non-neuronal-Postmitotic-Endothelial-Endothelial-24|World / Primary Cells by Cluster | 1.37e-05 | 199 | 11 | 3 | 0b4edf3e359749827ef978a77b5267ddde732d71 | |
| ToppCell | distal-mesenchymal-Pericyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.37e-05 | 199 | 11 | 3 | 000d9b5f5a48e56f0733390adb3d7270c49a4a1a | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.39e-05 | 200 | 11 | 3 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.39e-05 | 200 | 11 | 3 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | proximal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.39e-05 | 200 | 11 | 3 | 98cbd0f4994e645f70c0bc5ebc1c3a3b28c6b67f | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.39e-05 | 200 | 11 | 3 | b22cae282591d8dead9869c2adbb9632615f50f7 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.39e-05 | 200 | 11 | 3 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.39e-05 | 200 | 11 | 3 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | distal-3-mesenchymal-Pericyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.39e-05 | 200 | 11 | 3 | 911db29f254bb697610e720ba78816e2c7f57933 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.39e-05 | 200 | 11 | 3 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.39e-05 | 200 | 11 | 3 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | proximal-mesenchymal-Pericyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.39e-05 | 200 | 11 | 3 | 03119a979bc912a98e6fc87addcbc25d8ecf2fb0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.39e-05 | 200 | 11 | 3 | b5b5a32925f225610fe25a021a742d6397162863 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 1.39e-05 | 200 | 11 | 3 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.39e-05 | 200 | 11 | 3 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.39e-05 | 200 | 11 | 3 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.39e-05 | 200 | 11 | 3 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.39e-05 | 200 | 11 | 3 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 1.39e-05 | 200 | 11 | 3 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.39e-05 | 200 | 11 | 3 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| Drug | Linuron | 3.05e-07 | 128 | 11 | 4 | ctd:D008044 | |
| Drug | procymidone | 6.57e-07 | 155 | 11 | 4 | ctd:C035988 | |
| Drug | gamma-secretase inhibitor I | 1.27e-06 | 4 | 11 | 2 | CID011754711 | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.54e-06 | 192 | 11 | 4 | 5216_UP | |
| Drug | vgBE | 3.18e-06 | 6 | 11 | 2 | CID000193461 | |
| Drug | MW167 | 4.45e-06 | 7 | 11 | 2 | CID010312597 | |
| Drug | prochloraz | 5.80e-06 | 268 | 11 | 4 | ctd:C045362 | |
| Drug | lead stearate | 7.82e-06 | 84 | 11 | 3 | CID000061258 | |
| Drug | azoxystrobin | 9.00e-06 | 88 | 11 | 3 | CID003034285 | |
| Drug | Dichlorodiphenyl Dichloroethylene | 9.31e-06 | 302 | 11 | 4 | ctd:D003633 | |
| Drug | epoxiconazole | 1.50e-05 | 341 | 11 | 4 | ctd:C109476 | |
| Drug | (3Z)-3-[3-(hydroxyamino)indolin-2-ylidene]oxindole | 4.43e-05 | 21 | 11 | 2 | CID016073041 | |
| Drug | 1-piperidinocyclohexanecarbonitrile | 6.33e-05 | 25 | 11 | 2 | CID000062529 | |
| Drug | AC1NRAEN | 9.16e-05 | 30 | 11 | 2 | CID005287841 | |
| Drug | (S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 9.70e-05 | 195 | 11 | 3 | 5325_UP | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 9.85e-05 | 196 | 11 | 3 | 6464_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 9.85e-05 | 196 | 11 | 3 | 4100_DN | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 9.85e-05 | 196 | 11 | 3 | 6715_UP | |
| Drug | Cinnarizine [298-57-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 11 | 3 | 7174_UP | |
| Drug | Sulfamethizole [144-82-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | 1.00e-04 | 197 | 11 | 3 | 5798_UP | |
| Drug | AC1L9NAZ | 1.02e-04 | 198 | 11 | 3 | CID000449606 | |
| Drug | Loracarbef [121961-22-6]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 1.02e-04 | 198 | 11 | 3 | 5492_UP | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; HL60; HT_HG-U133A | 1.02e-04 | 198 | 11 | 3 | 2175_UP | |
| Drug | Proxyphylline [603-00-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 1.03e-04 | 199 | 11 | 3 | 7290_UP | |
| Drug | fluorescein-5-maleimide | 1.04e-04 | 32 | 11 | 2 | CID000122038 | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.05e-04 | 200 | 11 | 3 | 5601_UP | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 1.05e-04 | 200 | 11 | 3 | 5991_UP | |
| Drug | CHAPSO | 1.48e-04 | 38 | 11 | 2 | CID000122145 | |
| Drug | AC1NRBNZ | 3.46e-04 | 58 | 11 | 2 | CID005288543 | |
| Drug | 2-nitroisocitrate | 3.95e-04 | 62 | 11 | 2 | CID000166578 | |
| Drug | A25152 | 3.95e-04 | 62 | 11 | 2 | CID000002956 | |
| Drug | pyrachlostrobin | 4.32e-04 | 811 | 11 | 4 | ctd:C513428 | |
| Drug | GDP-fucose | 4.75e-04 | 68 | 11 | 2 | CID000000451 | |
| Drug | R59949 | 5.03e-04 | 70 | 11 | 2 | CID000657356 | |
| Drug | Dale | 5.18e-04 | 71 | 11 | 2 | CID005486816 | |
| Drug | Deoxyglucose | 5.62e-04 | 74 | 11 | 2 | ctd:D003847 | |
| Drug | Thromstop | 5.62e-04 | 74 | 11 | 2 | CID000004406 | |
| Drug | rhamnose | 5.70e-04 | 356 | 11 | 3 | CID000000840 | |
| Drug | Androgen Antagonists | 5.78e-04 | 75 | 11 | 2 | ctd:D000726 | |
| Drug | SureCN2313095 | 5.93e-04 | 76 | 11 | 2 | CID011840973 | |
| Drug | AC1L9M2J | 5.93e-04 | 76 | 11 | 2 | CID000448538 | |
| Drug | AG213 | 8.12e-04 | 89 | 11 | 2 | CID005328803 | |
| Drug | Atropine | 8.86e-04 | 93 | 11 | 2 | ctd:D001285 | |
| Disease | Squamous cell carcinoma | 9.58e-08 | 124 | 11 | 4 | C0007137 | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.90e-07 | 32 | 11 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Skin Neoplasms | 1.24e-06 | 59 | 11 | 3 | C0037286 | |
| Disease | Malignant neoplasm of skin | 1.24e-06 | 59 | 11 | 3 | C0007114 | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.65e-06 | 7 | 11 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.65e-06 | 7 | 11 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | Glioblastoma | 3.00e-06 | 79 | 11 | 3 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 3.61e-06 | 84 | 11 | 3 | C0334588 | |
| Disease | Squamous cell carcinoma of esophagus | 5.24e-06 | 95 | 11 | 3 | C0279626 | |
| Disease | Glioblastoma Multiforme | 8.36e-06 | 111 | 11 | 3 | C1621958 | |
| Disease | Mammary Neoplasms, Human | 2.96e-05 | 525 | 11 | 4 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 2.96e-05 | 525 | 11 | 4 | C4704874 | |
| Disease | Mammary Neoplasms | 3.00e-05 | 527 | 11 | 4 | C1458155 | |
| Disease | Breast Carcinoma | 3.26e-05 | 538 | 11 | 4 | C0678222 | |
| Disease | Carcinoma, Pancreatic Ductal | 3.47e-05 | 24 | 11 | 2 | C0887833 | |
| Disease | brain cancer (implicated_via_orthology) | 4.09e-05 | 26 | 11 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.51e-05 | 195 | 11 | 3 | DOID:1574 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 5.46e-05 | 30 | 11 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | obesity (implicated_via_orthology) | 6.03e-05 | 215 | 11 | 3 | DOID:9970 (implicated_via_orthology) | |
| Disease | cervical cancer | 7.04e-05 | 34 | 11 | 2 | C4048328 | |
| Disease | Uterine Cervical Neoplasm | 7.47e-05 | 35 | 11 | 2 | C0007873 | |
| Disease | Lung Neoplasms | 1.12e-04 | 265 | 11 | 3 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.13e-04 | 266 | 11 | 3 | C0242379 | |
| Disease | cancer (implicated_via_orthology) | 1.16e-04 | 268 | 11 | 3 | DOID:162 (implicated_via_orthology) | |
| Disease | cholesteryl ester 20:4 measurement | 1.19e-04 | 44 | 11 | 2 | EFO_0010348 | |
| Disease | cholesteryl ester 20:5 measurement | 1.19e-04 | 44 | 11 | 2 | EFO_0010349 | |
| Disease | systemic scleroderma | 4.44e-04 | 85 | 11 | 2 | EFO_0000717 | |
| Disease | Malignant neoplasm of breast | 4.69e-04 | 1074 | 11 | 4 | C0006142 | |
| Disease | Oral ulcer | 7.01e-04 | 107 | 11 | 2 | HP_0000155 | |
| Disease | C-reactive protein measurement | 7.27e-04 | 1206 | 11 | 4 | EFO_0004458 | |
| Disease | Bladder Neoplasm | 1.20e-03 | 140 | 11 | 2 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.21e-03 | 141 | 11 | 2 | C0005684 | |
| Disease | Non-Small Cell Lung Carcinoma | 1.48e-03 | 156 | 11 | 2 | C0007131 | |
| Disease | eosinophil count | 1.60e-03 | 1488 | 11 | 4 | EFO_0004842 | |
| Disease | Neoplasm Invasiveness | 2.05e-03 | 184 | 11 | 2 | C0027626 | |
| Disease | linoleic acid measurement | 2.09e-03 | 186 | 11 | 2 | EFO_0006807 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HESCLGQQVPCCDPC | 91 | O00253 | |
| CEDPCAQAPCEQQCE | 271 | Q9HCU0 | |
| CHRMEQNECECPCEC | 961 | Q5VU97 | |
| QNECECPCECPLEVN | 966 | Q5VU97 | |
| NCDCCRPDVGPCHEC | 16 | Q6IC83 | |
| LCEENIDNCDPDPCH | 566 | Q04721 | |
| CDQDINDCDPNPCLN | 846 | Q9UM47 | |
| CEQEVDPCLAQPCQH | 1081 | Q9UM47 | |
| ENSECIQCHPECLPQ | 551 | P00533 | |
| NHPAEQCCCCEQEEP | 611 | Q9Y4D2 | |
| CQECRCQEGHAHCQP | 566 | Q6ZWJ8 | |
| RQGPHDCCPQCSDCE | 1006 | Q6ZWJ8 | |
| PDCEVNPDNCVSHQC | 271 | Q99466 | |
| SCNPQDCVPEVDENC | 961 | Q6ZMP0 |